Amyloid formation in denatured single-mutant lysozymes where residual structures are modulated

Protein Science

Volumn 15, Issue 10, 2006, Pages 2448-2452

  Mishima, Tomonori ^a   Ohkuri, Takatoshi ^a   Monji, Akira ^b   Imoto, Taiji ^c   Ueda, Tadashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

Amyloid formation; Lysozyme; Residual structure

Indexed keywords

AMYLOID; LYSOZYME; THIOFLAVINE;

ALKYLATION; ARTICLE; CONTROLLED STUDY; DENATURATION; FLUORESCENCE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMYLOID; ANIMALS; CHICKENS; CIRCULAR DICHROISM; FLUORESCENCE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYDROPHOBICITY; MURAMIDASE; MUTATION, MISSENSE; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN DENATURATION; THIAZOLES;

EID: 33749321215     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062258206     Document Type: Article

References (33)

1. Bellotti, V., Mangione, P., and Merlini, G. 2000. Review: Immunoglobulin light chain amyloidosis - The archetype of structural and pathogenic variability. J. Struct. Biol. 130: 280-289.
2. Calamai, M., Chiti, F., and Dobson, C.M. 2005. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys. J. 89: 4201-4210.
3. Cao, A., Hu, D., and Lai, L. 2004. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 13: 319-324.
4. Chakraborty, C., Nandi, S., and Jana, S. 2005. Prion disease: A deadly disease for protein misfolding. Curr. Pharm. Biotechnol. 6: 167-177.
5. Damaschun, G., Damaschun, H., Fabian, H., Gast, K., Krober, R., Wieske, M., and Zirwer, D. 2000. Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 39: 204-211.
6. Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24: 329-332.
7. _. 2003. Protein folding and misfolding. Nature 426: 884-890.
8. Frare, E., Polverino De Laureto, P., Zurdo, J., Dobson, C.M., and Fontana, A. 2004. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 23: 1153-1165.
9. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D., and Dobson, C.M. 1998. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. 95: 4224-4228.
10. Imoto, T., Johnson, L.N., North, A.C.T., Philip, D.C., and Rupley, J. 1972. Vertebrate lysozyme. In The Enzymes, 3d ed., (ed. P.D. Boyer), Vol. 7, pp. 665-863. Academic Press, New York.
11. Jahn, T.R., Parker, M.J., Homans, S.W., and Radford, S.E. 2006. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat. Struct. Mol. Biol. 13: 195-201.
12. Klein-Seetharaman, J., Oikawa, M., Grimshaw, S.B., Wirmer, J., Duchardt, E., Ueda, T., Imoto, T., Smith, L.J., Dobson, C.M., and Schwalbe, H. 2002. Long-range interactions within a nonnative protein. Science 295: 1719-1722.
13. Konno, T., Murata, K., and Nagayama, K. 1999. Amyloid-like aggregates of a plant protein: A case of a sweet-tasting protein, monellin. FEBS Lett. 454: 122-126.
14. LeVine, H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2: 404-410.
15. Lietzow, M.A., Jamin, M., Jane Dyson, H.J., and Wright, P.E. 2002. Mapping long-range contacts in a highly unfolded protein. J. Mol. Biol. 322: 655-662.
16. Lopez de La Paz, M., Goldie, K., Zurdo, J., Lacroix, E., Dobson, C.M., Hoenger, A., and Serrano, L. 2002. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. 99: 16052-16057.
17. 15N-labeled hen lysozyme in Pichia pastoris and identification of the site in hen lysozyme where phosphate ion binds using NMR measurements. FEBS Lett. 448: 33-37.
18. Niraula, T.N., Konno, T., Li, H., Yamada, H., Akasaka, K., and Tachibana, H. 2004. Pressure-dissociable reversible assembly of intrinsically denatured lysozyme is a precursor for amyloid fibrils. Proc. Natl. Acad. Sci. 101: 4089-4093.
19. Ohkuri, T., Shioi, S., Imoto, T., and Ueda, T. 2005. Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form. J. Mol. Biol. 347: 159-168.
20. Pavlov, N.A., Cherny, D.I., Heim, G., Jovin, T.M., and Subramaniam, V. 2002. Amyloid fibrils from the mammalian protein prothymosin α. FEBS Lett. 517: 37-40.
21. Pertinhez, T.A., Bouchard, M., Tomlinson, E.J., Wain, R., Ferguson, S.J., Dobson, C.M., and Smith, L.J. 2001. Amyloid fibril formation by a helical cytochrome. FEBS Lett. 495: 184-186.
22. Schwalbe, H., Fiebig, K.M., Buck, M., Jones, J.A., Grimshaw, S.B., Spencer, A., Glaser, S.J., Smith, L.J., and Dobson, C.M. 1997. Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea. Biochemistry 36: 8977-8991.
23. Shortle, D. and Ackerman, M.S. 2001. Persistence of native-like topology in a denatured protein in 8 M urea. Science 293: 487-489.
24. Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., and Blake, C.C. 1997. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273: 729-739.
25. Ueda, T., Yamada, H., Aoki, H., and Imoto, T. 1990. Effect of chemical modifications of tryptophan residues on the folding of reduced hen egg-white lysozyme. J. Biochem. 108: 886-892.
26. Ueda, T., Abe, Y., Ohkuri, T., Kawano, K., Terada, Y., and Imoto, T. 1995. Kinetically trapped structure in the renaturation of reduced oxindolealanine 62 lysozyme. Biochemistry 34: 16178-16185.
27. Ueda, T., Ohkuri, T., and Imoto, T. 1996. Identification of the peptide region that folds native conformation in the early stage of the renaturation of reduced lysozyme. Biochem. Biophys. Res. Commun. 228: 203-208.
28. Uversky, V.N. 2003. A protein-chameleon: Conformational plasticity of α-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 21: 211-234.
29. Uversky, V.N. and Fink, A.L. 2004. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim. Biophys. Acta 1698: 131-153.
30. Veerhuis, R., Boshuizen, R.S., and Familian, A. 2005. Amyloid associated proteins in Alzheimer's and prion disease. Curr. Drug Targets CNS Neurol. Disord. 4: 235-248.
31. Wagner, G. 1993. NMR relaxation and protein mobility. Curr. Opin. Struct. Biol. 3: 748-754.
32. Wirmer, J., Schlorb, C., Klein-Seetharaman, J., Hirano, R., Ueda, T., Imoto, T., and Schwalbe, H. 2004. Modulation of compactness and long-range interactions of unfolded lysozyme by single point mutations. Angew. Chem. Int. Ed. Engl. 43: 5780-5785.
33. Yutani, K., Takayama, G., Goda, S., Yamagata, Y., Maki, S., Namba, K., Tsunasawa, S., and Ogasahara, K. 2000. The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile Pyrococcus furiosus. Biochemistry 39: 2769-2777.